ARCHIVES

“What Is Good For NCI Is Good For NIH,” Broder Says In Address

This article is from The Cancer Letter archive.

Vol. 21 No. 02 | January 13, 1995

Download PDF Visit The Full Archive

Related Articles

Letter to the Editors: Society of Toxicology Comments On President’s Cancer Panel Report

August 6, 2010

FDA Proposes Office For Patients With Life Threatening Disease

November 13, 1992

Young Molecular Biologists Optimistic, Survey Finds

February 21, 1997

Trials Approved In October

December 28, 2001

NCI, Advisors Concur On Need For New Mechanism To Include Cancer Control, Minority Center Needs

September 21, 1984

FDA to Move Away From Central Radiology To Investigator Review In PFS Endpoint Trials

July 27, 2012